Markets:

Overview

News

Currencies

International

Treasuries

Natera, Inc. - Common Stock (NQ:NTRA)

235.04 -19.36 (-7.61%)

Streaming Delayed Price Updated: 1:23 PM EST, Jan 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Natera, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

18 19 Next >

Why Natera (NTRA) Stock Is Trading Lower Today

September 12, 2025

Shares of genetic testing company Natera (NASDAQ:NTRA). fell 2.7% in the afternoon session after the company reached an $8.25 million settlement in a legal case. The case, titled 'Amanda Davis v....

Via StockStory

Topics Artificial Intelligence Lawsuit

Why Natera (NTRA) Shares Are Falling Today

September 10, 2025

Shares of genetic testing company Natera (NASDAQ:NTRA). fell 4.1% in the afternoon session after a key competitor, Exact Sciences, announced the launch of a new multi-cancer early detection blood...

Via StockStory

Topics Intellectual Property

3 Reasons We’re Fans of Natera (NTRA)

September 10, 2025

Since September 2020, the S&P 500 has delivered a total return of 94.8%. But one standout stock has doubled the market - over the past five years, Natera has surged 186% to $176.64 per share. Its...

Via StockStory

Topics Stocks

5 Analysts Have This To Say About Natera ↗

August 11, 2025

Via Benzinga

How Is The Market Feeling About Natera? ↗

August 08, 2025

Via Benzinga

1 Cash-Producing Stock to Own for Decades and 2 We Find Risky

September 01, 2025

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Via StockStory

Topics Supply Chain

Why Natera (NTRA) Stock Is Down Today

August 29, 2025

Shares of genetic testing company Natera (NASDAQ:NTRA). fell 0.9% in the morning session after the company announced an unfavorable court ruling in its ongoing patent litigation with competitor...

Via StockStory

Topics Intellectual Property

NeoGenomics Gains 'Unexpected' Win As Court Rejects Natera Claims ↗

August 29, 2025

NeoGenomics wins a North Carolina court ruling invalidating key Natera patents, clearing the way for its RaDaR ST assay and boosting investor sentiment.

Via Benzinga

Topics Intellectual Property

Natera Provides Update on Patent Litigation with NeoGenomics

August 29, 2025

From Natera, Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

August 29, 2025

Via Benzinga

Why Natera (NTRA) Stock Is Up Today

August 28, 2025

Shares of genetic testing company Natera (NASDAQ:NTRA). jumped 3% in the afternoon session after the company announced its Signatera molecular residual disease test was selected for a Phase III...

Via StockStory

Topics Earnings

Signatera™ Test Selected for NRG-Sponsored Phase III ARCHER Trial in Bladder Cancer

August 28, 2025

From Natera, Inc.

Via Business Wire

2 Cash-Heavy Stocks Worth Investigating and 1 We Ignore

August 27, 2025

A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face challenges like stagnating revenue, declining...

Via StockStory

Natera to Present Signatera™ Data at the IASLC World Conference on Lung Cancer

August 25, 2025

From Natera, Inc.

Via Business Wire

Natera Technology Featured in 300+ Peer-Reviewed Publications, Underscoring Scientific Leadership in Precision Medicine

August 22, 2025

From Natera, Inc.

Via Business Wire

Natera Launches Proprietary AI Foundation Models to Accelerate Diagnostic and Therapeutic Innovation

August 22, 2025

From Natera, Inc.

Via Business Wire

1 Healthcare Stock to Own for Decades and 2 We Find Risky

August 22, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But financial performance has lagged recently as players offloaded surplus COVID...

Via StockStory

Topics Retirement Stocks

IMvigor011 Bladder Cancer Trial Achieves Positive Results, with Signatera™ Strongly Predicting Adjuvant Immunotherapy Benefit

August 18, 2025

From Natera, Inc.

Via Business Wire

$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today ↗

August 12, 2025

Via Benzinga

NTRA Q2 Deep Dive: Oncology Growth, Product Innovation, and Margin Pressures

August 12, 2025

Genetic testing company Natera (NASDAQ:NTRA). reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 32.2% year on year to $546.6 million. The company’s full-year revenue...

Via StockStory

Topics Artificial Intelligence

2 Mid-Cap Stocks on Our Watchlist and 1 We Brush Off

August 12, 2025

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract...

Via StockStory

1 of Wall Street’s Favorite Stock to Own for Decades and 2 We Turn Down

August 11, 2025

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because...

Via StockStory

Tech Stocks Eye Record Highs As Magnificent Seven Top $19.5 Trillion: What's Moving Markets Friday? ↗

August 08, 2025

Tech stocks staged a full rebound from last Friday's sell-off, with the Nasdaq 100 surging to 23,600 — just shy of the 23,700 all-time high set in late July, as the week’s strong sector earnings and...

Via Benzinga

Why Are Natera (NTRA) Shares Soaring Today

August 08, 2025

Shares of genetic testing company Natera (NASDAQ:NTRA). jumped 11.6% in the morning session after it reported strong second-quarter 2025 financial results, including a significant revenue beat and...

Via StockStory

Topics Earnings World Trade

SoundHound AI, Ouster, Globalstar, Doximity, JFrog And Other Big Stocks Moving Higher On Friday ↗

August 08, 2025

Via Benzinga

Topics Artificial Intelligence

Natera (NASDAQ:NTRA) Delivers Strong Q2 Numbers, Stock Jumps 12.6%

August 08, 2025

Genetic testing company Natera (NASDAQ:NTRA). reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 32.2% year on year to $546.6 million. The company’s full-year revenue...

Via StockStory

Natera NTRA Q2 2025 Earnings Call Transcript ↗

August 07, 2025

Via The Motley Fool

Topics Earnings

Natera (NTRA) Q2 Revenue Jumps 32% ↗

August 07, 2025

Via The Motley Fool

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

August 07, 2025

Via Benzinga

Natera Reports Second Quarter 2025 Financial Results

August 07, 2025

From Natera, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.